- Last Close 0
- Sector Healthcare
- Industry Biotechnology
- Investment Style
- Day Range < 0.01 – < 0.01
- Year Range < 0.01 – < 0.01
- Market Cap —
- Volume / Avg 50,000.0 / 50,000.0
- Price / Sales —
- Price / Book —
- Forward Div Yield —
- Trailing Div Yield —
Morningstar‘s Stock Analysis GHTI
Morningstar Quantitative ratings for equities (denoted on this page by) are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies withratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating. Click here for more on how to use these ratings.
Company Profile GHTI
G-H-3 International Inc develops products for anti-aging and deterioration in the body.It manufactures health care products that promote anti-aging, treats chronic disease, and improve health and vitality.
Las Vegas, NV, 89120
FAQs for G-H-3 International Inc Stock
No. GHTI does not currently have a forward dividend yield.
Dividend yield allows investors, particularly those interested in dividend-paying stocks, to compare the relationship between a stock’s price and how it rewards stockholders through dividends. The formula for calculating dividend yield is to divide the annual dividend paid per share by the stock price.
Learn more about dividend yield.
GHTI’s beta can be found in Trading Information at the top of this page.
A stock’s beta measures how closely tied its price movements have been to the performance of the overall market.
Compare GHTI’s historical performance against its industry peers and the overall market.